Metraipolis › archive › dc_7bd6f1a2fceb

Impact of dapagliflozin on bone mineral metabolism in non-diabetic patients with chronic kidney disease: a randomized, double-blind, placebo-controlled study — Europe PMC PMID:41800320

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41800320
DOI
10.1093/ckj/sfaf384
License (as archived)
solo-consultazione
Archived
2026-11-07T18:37:09.937Z
SHA-256 of the archived text
4a21e5dbb07482488d94f77402d93a2217d38a35806e9dc3025132f99ea9efd1
Stable URL of this page
https://metraipolis.com/documento/dc_7bd6f1a2fceb

How to cite

Impact of dapagliflozin on bone mineral metabolism in non-diabetic patients with chronic kidney disease: a randomized, double-blind, placebo-controlled study — Europe PMC PMID:41800320 — Europe PMC (en), https://europepmc.org/article/MED/41800320 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7bd6f1a2fceb (Metraipolis archive dc_7bd6f1a2fceb, sha256 4a21e5dbb07482488d94f77402d93a2217d38a35806e9dc3025132f99ea9efd1)
BibTeX
@misc{dc7bd6f1a2fceb,
  title = {Impact of dapagliflozin on bone mineral metabolism in non-diabetic patients with chronic kidney disease: a randomized, double-blind, placebo-controlled study — Europe PMC PMID:41800320},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41800320},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7bd6f1a2fceb; sha256 4a21e5dbb07482488d94f77402d93a2217d38a35806e9dc3025132f99ea9efd1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41800320. Agents can read the archived copy with the MCP tool read_document.